An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia
Condition: Sickle Cell Disease Intervention: Drug: IMR-687 Sponsor: Imara, Inc. Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials